Skip to Content

Sucralfate Oral Presentations

Last Updated: March 8, 2012
Status: Resolved

Products Affected - Description

All products are now available.

Reason for the Shortage

  • Teva, Watson and Axcan could not provide a reason for the shortage.
  • UDL temporaroli discontinued their sucralfate products due to a raw materials shortage.

Available Products

Carafate tablets Aptalis (formerly Axcan)
1 gram, 100 count (NDC 58914-0171-10)

Carafate oral liquid 1 gram/10 mL, Aptalis (formerly Axcan)
14 fluid ounce bottle (NDC 58914-0170-14)

Sucralfate tablets, Nostrum

1 gram, 100 count (NDC 29033-0003-01)
1 gram, 500 count (NDC 29033-0003-05)
 
Sucralfate tablets, Teva
1 gram, 100 count (NDC 00093-2210-01)
1 gram, 500 count (NDC 00093-2210-05)
 
Sucralfate tablets, UDL
1 gram, 25 count unit-dose, robot-ready (NDC 51079-0871-19)
1 gram, 100 count unit-dose (NDC 51079-0871-20)
 
Sucralfate oral liquid 1 gram/10 mL, VistaPharm
10 mL unit-dose, 50 count (NDC 66689-0790-50)
 
Sucralfate tablets, Watson
1 gram, 100 count (NDC 00591-0780-01)
1 gram, 500 count (NDC 00591-0780-05)

Estimated Resupply Dates

All products are now available.

Updated

March 8, 2012; February 16, 2012; January 31, 2012; January 3, 2012; November 18, 2011; November 4, 2011; October 12, 2011; September 28, 2011; September 21, 2011; September 7, 2011; July 26, 2011; June 16, 2011; May 11, 2011; April 19, 2011, University of Utah, Drug Information Service. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide